Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices 76147 

or the sale within the United States after 

importation of components for certain 

environmentally-protected LCD digital 

displays and products containing same 

by reason of infringement of certain 

claims of U.S. Patent Nos. 7,948,575 

(‘‘the ’575 patent’’); 8,111,348 (‘‘the ’348 

patent’’); RE45,117 (‘‘the ’117 patent’’); 

8,842,253 (‘‘the ’253 patent’’); and 

8,223,311 (‘‘the ’311 patent’’). Id. The 

Commission’s notice of investigation 

named Manufacturing Resources 

International, Inc. (‘‘MRI’’) of 

Alpharetta, Georgia as the sole 

respondent. The Office of Unfair Import 

Investigations was not named as a party 

in this investigation. Id. 

On October 10, 2023, the Commission 

determined not to review an initial 

determination terminating the 

investigation as to all asserted claims of 

the ’575 patent; all asserted claims of 

the ’348 patent; claim 5 of the ’117 

patent; claims 1, 10, 11, and 16–19 of 

the ’253 patent; and claims 1–3 and 7– 

12 of the ’311 patent. Order No. 22, 

unreviewed by Comm’n Notice (Oct. 10, 

2023). 

On April 16, 2024, the presiding 

administrative law judge issued a final 

initial determination (‘‘final ID’’) on 

violation of section 337 and a 

recommended determination on remedy 

and bond. The final ID held that no 

violation of section 337 has occurred in 

the importation into the United States, 

the sale for importation, or the sale 

within the United States after 

importation of components of certain 

environmentally-protected LCD digital 

displays and products containing the 

same by reason of infringement of 

claims 1 and 2 of the ’117 patent, claims 

4, 6, and 13 of the ’311 patent, and 

claim 12 of the ’253 patent. 

On June 17, 2024, the Commission 

determined to review the final ID in 

part. See 89 FR 52505 (June 24, 2024). 

The Commission asked the parties to 

address a number of questions related to 

the issues under review. Id. at 52506– 

07. 

On July 1, 2024, Samsung and MRI 

each filed an initial written response to 

the Commission’s request for briefing. 

On July 9, 2024, the parties each filed 

a reply submission. 

On August 13, 2024, the parties filed 

a Joint Motion to Stay Investigation and 

Extend Target Date. The parties stated 

they have agreed to resolve the 

investigation based on the terms of the 

Binding Term Sheet (Ex. A), but 

requested that the Commission stay the 

investigation and extend the target date 

to August 30, 2024, to allow the parties 

time to execute a final settlement 

agreement and file a motion to terminate 

the investigation. The Commission 

granted the motion, stayed the 

investigation, and extended the target 

date for completion of the investigation 

to September 16, 2024. Comm’n Notice 

(Aug. 16, 2024). 

On August 28, 2024, the parties filed 

a Joint Motion for Termination by 

Settlement (‘‘Motion’’). The parties 

submitted the executed settlement 

agreement as Exhibit A to the Motion. 

The Commission has determined that 

the Motion complies with the 

requirements of Rule 210.21(b)(1) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 210.21(b)(1)), and 

that there are no extraordinary 

circumstances that would prevent the 

requested termination. The Commission 

also finds that granting the Motion 

would not be contrary to the public 

interest pursuant to Rule 210.50(b)(2) of 

the Commission’s Rules of Practice and 

Procedure (19 CFR 210.50(b)(2)). 

Accordingly, the Commission hereby 

grants the Motion. The Commission 

takes no position as to the issues that 

remain under review. 

This investigation is terminated. 

The Commission vote for this 

determination took place on September 

12, 2024. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: September 12, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–21114 Filed 9–16–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1431] 

Bulk Manufacturer of Controlled 

Substances Application: Chemtos, 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Chemtos, LLC has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before November 18, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before November 18, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on August 5, 2024, 

Chemtos, LLC, 16713 Picadilly Court, 

Round Rock, Texas 78664–8544, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Amineptine ................................................................................................................................................................................... 1219 I 

Mesocarb ..................................................................................................................................................................................... 1227 I 

3-Fluoro-N-methylcathinone (3–FMC) ......................................................................................................................................... 1233 I 

Cathinone .................................................................................................................................................................................... 1235 I 

Methcathinone ............................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4–FMC) ......................................................................................................................................... 1238 I 

Pentedrone (a-methylaminovalerophenone) ............................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) ................................................................................................................................ 1248 I 


ddrumheller on DSK120RN23PROD with NOTICES1
76148 Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices 

Controlled substance Drug 

code Schedule 

4-Methyl-N-ethylcathinone (4–MEC) ........................................................................................................................................... 1249 I 

Naphyrone ................................................................................................................................................................................... 1258 I 

3–MMC; 3–METHYLMETHCATHINONE .................................................................................................................................... 1259 I 

N-Ethylamphetamine ................................................................................................................................................................... 1475 I 

Methiopropamine ......................................................................................................................................................................... 1478 I 

N,N-Dimethylamphetamine .......................................................................................................................................................... 1480 I 

Fenethylline ................................................................................................................................................................................. 1503 I 

Aminorex ...................................................................................................................................................................................... 1585 I 

4-Methylaminorex (cis isomer) .................................................................................................................................................... 1590 I 

Gamma Hydroxybutyric Acid ....................................................................................................................................................... 2010 I 

Methaqualone .............................................................................................................................................................................. 2565 I 

Mecloqualone .............................................................................................................................................................................. 2572 I 

ETIZOLAM ................................................................................................................................................................................... 2780 I 

FLUALPRAZOLAM ...................................................................................................................................................................... 2785 I 

CLONAZOLAM ............................................................................................................................................................................ 2786 I 

FLUBROMAZOLAM .................................................................................................................................................................... 2788 I 

DICLAZEPAM .............................................................................................................................................................................. 2789 I 

JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .............................................................................................................. 6250 I 

SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ............................................................ 7008 I 

ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ......................... 7010 I 

5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ............................ 7011 I 

AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ................................. 7012 I 

FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ........................................................... 7014 I 

JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .................................................................................................................................. 7019 I 

MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .................................. 7020 I 

FUB–AMB, MMB- FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ...... 7021 I 

AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..................................................... 7023 I 

THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ............................................................................... 7024 I 

5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) .................................... 7025 I 

ADB–BUTINACA ......................................................................................................................................................................... 7027 

AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide ............................. 7031 I 

MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .................... 7032 I

5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .......................................................... 7033 I 

5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .................. 7034 I 

ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ............................................. 7035 I 

5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..................................... 7036 I 

5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) .......................................... 7041 I 

MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ...... 7042 I 

MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) .................... 7044 I 

FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3- 

carboximide).

7047 I 

APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .......................................................................... 7048 I 

5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .............................................. 7049 I 

JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .............................................................................................................. 7081 I 

5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ................................ 7083 I 

5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ........................... 7085 I 

4–CN–CUML–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1-(4- 

cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).

7089 I 

4F–MDMB–BUTICA; 4F–MDMB–BICA ....................................................................................................................................... 7091 I 

ADB–4EN–PINACA ..................................................................................................................................................................... 7092 I 

CUMYL–PEGACLONE; SGT–151 .............................................................................................................................................. 7093 I 

5F–EDMB–PICA; 5F–EDMB–2201 ............................................................................................................................................. 7094 I 

MMB–FUBICA ............................................................................................................................................................................. 7095 I 

SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ................................................................................ 7104 I 

JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .......................................................................................... 7118 I 

JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ................................................................................................................. 7122 I 

UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ............................................................................. 7144 I 

JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ................................................................................................................................... 7173 I 

JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ...................................................................................................... 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ................................................................................................................... 7201 I 

JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .................................................................................................................. 7203 I 

NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ...................................................................... 7221 I 

PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ............................................................................................................. 7222 I 

5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ........................................................................................ 7225 I 

4–MEAP (4-Methyl-alpha-ethylaminopentiophenone) ................................................................................................................. 7245 I 

N-Ethylhexedrone ........................................................................................................................................................................ 7246 I 

Alpha-ethyltryptamine .................................................................................................................................................................. 7249 I 

Ibogaine ....................................................................................................................................................................................... 7260 I 

CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ............................................................................ 7297 I 

CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...................................................... 7298 I 

Lysergic acid diethylamide .......................................................................................................................................................... 7315 I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) .......................................................................................................... 7348 I 

Marihuana Extract ....................................................................................................................................................................... 7350 I 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices 76149 

Controlled substance Drug 

code Schedule 

Marihuana .................................................................................................................................................................................... 7360 I 

Tetrahydrocannabinols ................................................................................................................................................................ 7370 I 

Parahexyl ..................................................................................................................................................................................... 7374 I 

Mescaline ..................................................................................................................................................................................... 7381 I 

2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ...................................................................................................... 7385 I 

3,4,5-Trimethoxyamphetamine .................................................................................................................................................... 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ......................................................................................................................................... 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine ...................................................................................................................................... 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ......................................................................................................................................... 7395 I 

2,5-Dimethoxyamphetamine ........................................................................................................................................................ 7396 I 

JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .................................................................................................................. 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ............................................................................................................................................ 7399 I 

3,4-Methylenedioxyamphetamine ................................................................................................................................................ 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .............................................................................................................................. 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .............................................................................................................................. 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ................................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ........................................................................................................................................ 7405 I 

4-Methoxyamphetamine .............................................................................................................................................................. 7411 I 

5-Methoxy-N–N-dimethyltryptamine ............................................................................................................................................ 7431 I 

Alpha-methyltryptamine ............................................................................................................................................................... 7432 I 

Bufotenine .................................................................................................................................................................................... 7433 I 

Diethyltryptamine ......................................................................................................................................................................... 7434 I 

Dimethyltryptamine ...................................................................................................................................................................... 7435 I 

Psilocybin ..................................................................................................................................................................................... 7437 I 

Psilocyn ....................................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ......................................................................................................................................... 7439 I 

4′-Chloro-alpha-pyrrolidinovalerophenone ................................................................................................................................... 7443 I 

MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone ....................................................................................................................... 7446 I 

N-Ethyl-1-phenylcyclohexylamine ................................................................................................................................................ 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine ................................................................................................................................................ 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ........................................................................................................................................... 7470 I 

1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .......................................................................................................................................... 7473 I 

N-Ethyl-3-piperidyl benzilate ........................................................................................................................................................ 7482 I 

N-Methyl-3-piperidyl benzilate ..................................................................................................................................................... 7484 I 

N-Benzylpiperazine ...................................................................................................................................................................... 7493 I 

4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) ................................................................................................................. 7498 I 

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .............................................................................................................. 7508 I 

2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ................................................................................................................ 7509 I 

2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ............................................................................................................................. 7517 I 

2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) .................................................................................................................... 7518 I 

2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .............................................................................................................. 7519 I 

2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ................................................................................................................ 7521 I 

2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ......................................................................................................... 7524 I 

2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) .............................................................................................. 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ................................................................................................................................... 7535 I 

2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ................................................................ 7536 I 

2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ................................................................ 7537 I 

2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ..................................................................... 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) .................................................................................................................. 7540 I 

Butylone ....................................................................................................................................................................................... 7541 I 

Pentylone ..................................................................................................................................................................................... 7542 I 

N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ................................................................. 7543 I 

a-PHP, alpha-Pyrrolidinohexanophenone ................................................................................................................................... 7544 I 

alpha-pyrrolidinopentiophenone (a-PVP) .................................................................................................................................... 7545 I 

alpha-pyrrolidinobutiophenone (a-PBP) ...................................................................................................................................... 7546 I 

Ethylone ....................................................................................................................................................................................... 7547 I 

Eutylone ....................................................................................................................................................................................... 7549 I 

A–PIHP; ALPHA–PIHP ................................................................................................................................................................ 7551 I 

AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ............................................................................................................... 7694 I 

Acetyldihydrocodeine ................................................................................................................................................................... 9051 I 

Benzylmorphine ........................................................................................................................................................................... 9052 I 

Codeine-N-oxide .......................................................................................................................................................................... 9053 I 

Cyprenorphine ............................................................................................................................................................................. 9054 I 

Desomorphine ............................................................................................................................................................................. 9055 I 

Etorphine (except HCl) ................................................................................................................................................................ 9056 I 

Codeine methylbromide ............................................................................................................................................................... 9070 I 

Brorphine ..................................................................................................................................................................................... 9098 I 

Dihydromorphine ......................................................................................................................................................................... 9145 I 

Difenoxin ...................................................................................................................................................................................... 9168 I 

Heroin .......................................................................................................................................................................................... 9200 I 

Hydromorphinol ........................................................................................................................................................................... 9301 I 

Methyldesorphine ........................................................................................................................................................................ 9302 I 

Methyldihydromorphine ............................................................................................................................................................... 9304 I 


ddrumheller on DSK120RN23PROD with NOTICES1
76150 Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices 

Controlled substance Drug 

code Schedule 

Morphine methylbromide ............................................................................................................................................................. 9305 I 

Morphine methylsulfonate ........................................................................................................................................................... 9306 I 

Morphine-N-oxide ........................................................................................................................................................................ 9307 I 

Myrophine .................................................................................................................................................................................... 9308 I 

Nicocodeine ................................................................................................................................................................................. 9309 I 

Nicomorphine ............................................................................................................................................................................... 9312 I 

Normorphine ................................................................................................................................................................................ 9313 I 

Pholcodine ................................................................................................................................................................................... 9314 I 

Thebacon ..................................................................................................................................................................................... 9315 I 

Acetorphine .................................................................................................................................................................................. 9319 I 

Drotebanol ................................................................................................................................................................................... 9335 I 

U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .......................................................................... 9547 I 

AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .............................................................................. 9551 I 

MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) .............................................................................................................. 9560 I 

Acetylmethadol ............................................................................................................................................................................ 9601 I 

Allylprodine .................................................................................................................................................................................. 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol .................................................................................................................. 9603 I 

Alphameprodine ........................................................................................................................................................................... 9604 I 

Alphamethadol ............................................................................................................................................................................. 9605 I 

Benzethidine ................................................................................................................................................................................ 9606 I 

Betacetylmethadol ....................................................................................................................................................................... 9607 I 

Betameprodine ............................................................................................................................................................................ 9608 I 

Betamethadol ............................................................................................................................................................................... 9609 I 

Betaprodine ................................................................................................................................................................................. 9611 I 

Clonitazene .................................................................................................................................................................................. 9612 I 

Dextromoramide .......................................................................................................................................................................... 9613 I 

Isotonitazene ............................................................................................................................................................................... 9614 I 

Diampromide ............................................................................................................................................................................... 9615 I 

Diethylthiambutene ...................................................................................................................................................................... 9616 I 

Dimenoxadol ................................................................................................................................................................................ 9617 I 

Dimepheptanol ............................................................................................................................................................................. 9618 I 

Dimethylthiambutene ................................................................................................................................................................... 9619 I 

Dioxaphetyl butyrate .................................................................................................................................................................... 9621 I 

Dipipanone ................................................................................................................................................................................... 9622 I 

Ethylmethylthiambutene .............................................................................................................................................................. 9623 I 

Etonitazene .................................................................................................................................................................................. 9624 I 

Etoxeridine ................................................................................................................................................................................... 9625 I 

Furethidine ................................................................................................................................................................................... 9626 I 

Hydroxypethidine ......................................................................................................................................................................... 9627 I 

Ketobemidone .............................................................................................................................................................................. 9628 I 

Levomoramide ............................................................................................................................................................................. 9629 I 

Levophenacylmorphan ................................................................................................................................................................ 9631 I 

Morpheridine ................................................................................................................................................................................ 9632 I 

Noracymethadol ........................................................................................................................................................................... 9633 I 

Norlevorphanol ............................................................................................................................................................................ 9634 I 

Normethadone ............................................................................................................................................................................. 9635 I 

Norpipanone ................................................................................................................................................................................ 9636 I 

Phenadoxone ............................................................................................................................................................................... 9637 I 

Phenampromide .......................................................................................................................................................................... 9638 I 

Phenoperidine .............................................................................................................................................................................. 9641 I 

Piritramide .................................................................................................................................................................................... 9642 I 

Proheptazine ................................................................................................................................................................................ 9643 I 

Properidine .................................................................................................................................................................................. 9644 I 

Racemoramide ............................................................................................................................................................................ 9645 I 

Trimeperidine ............................................................................................................................................................................... 9646 I 

Phenomorphan ............................................................................................................................................................................ 9647 I 

Propiram ...................................................................................................................................................................................... 9649 I 

1-Methyl-4-phenyl-4-propionoxypiperidine .................................................................................................................................. 9661 I 

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .......................................................................................................................... 9663 I 

Tilidine ......................................................................................................................................................................................... 9750 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ............................................................................................. 9811 I 

Para-Fluorofentanyl ..................................................................................................................................................................... 9812 I 

3-Methylfentanyl .......................................................................................................................................................................... 9813 I 

Alpha-methylfentanyl ................................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ......................................................................................................................................................... 9815 I 

N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ................................................................................................... 9816 I 

Para-Methylfentanyl ..................................................................................................................................................................... 9817 I 

4′-Methyl Acetyl Fentanyl ............................................................................................................................................................ 9819 I 

Ortho-Methyl Methoxyacetyl Fentanyl ......................................................................................................................................... 9820 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ........................................................................................... 9821 I 

Butyryl Fentanyl ........................................................................................................................................................................... 9822 I 

Para-fluorobutyryl fentanyl ........................................................................................................................................................... 9823 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ..................................................... 9824 I 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices 76151 

Controlled substance Drug 

code Schedule 

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ..................................................................................................... 9825 I 

Para-chloroisobutyryl fentanyl ..................................................................................................................................................... 9826 I 

Isobutyryl fentanyl ........................................................................................................................................................................ 9827 I 

Beta-hydroxyfentanyl ................................................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl .................................................................................................................................................... 9831 I 

Alpha-methylthiofentanyl ............................................................................................................................................................. 9832 I 

3-Methylthiofentanyl ..................................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ......................................................................... 9834 I 

Thiofentanyl ................................................................................................................................................................................. 9835 I 

Beta-hydroxythiofentanyl ............................................................................................................................................................. 9836 I 

Para-methoxybutyryl fentanyl ...................................................................................................................................................... 9837 I 

Ocfentanil ..................................................................................................................................................................................... 9838 I 

Thiofuranyl Fentanyl .................................................................................................................................................................... 9839 I 

Valeryl fentanyl ............................................................................................................................................................................ 9840 I 

Phenyl fentanyl ............................................................................................................................................................................ 9841 I 

Beta’-Phenyl fentanyl ................................................................................................................................................................... 9842 I 

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ...................................................................................... 9843 I 

Crotonyl Fentanyl ........................................................................................................................................................................ 9844 I 

Cyclopropyl Fentanyl ................................................................................................................................................................... 9845 I 

Ortho-Fluorobutyryl Fentanyl ....................................................................................................................................................... 9846 I 

Cyclopentyl Fentanyl ................................................................................................................................................................... 9847 I 

Ortho-Methyl Acetylfentanyl ........................................................................................................................................................ 9848 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ................................................................................................. 9850 I 

Fentanyl Carbamate .................................................................................................................................................................... 9851 I 

Ortho-Fluoracryl Fentanyl ............................................................................................................................................................ 9852 I 

Ortho-Fluoroisobutyryl Fentanyl .................................................................................................................................................. 9853 I 

Para-Fluoro Furanyl Fentanyl ...................................................................................................................................................... 9854 I 

2′-Fluoro ortho-fluorofentanyl ...................................................................................................................................................... 9855 I 

Beta-Methyl Fentanyl ................................................................................................................................................................... 9856 I 

Zipeprol ........................................................................................................................................................................................ 9873 I 

Amphetamine ............................................................................................................................................................................... 1100 II 

Methamphetamine ....................................................................................................................................................................... 1105 II 

Lisdexamfetamine ........................................................................................................................................................................ 1205 II 

Phenmetrazine ............................................................................................................................................................................. 1631 II 

Methylphenidate .......................................................................................................................................................................... 1724 II 

Amobarbital .................................................................................................................................................................................. 2125 II 

Pentobarbital ................................................................................................................................................................................ 2270 II 

Secobarbital ................................................................................................................................................................................. 2315 II 

Glutethimide ................................................................................................................................................................................. 2550 II 

Nabilone ....................................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ............................................................................................................................................................ 7460 II 

Phencyclidine ............................................................................................................................................................................... 7471 II 

4-Anilino-N-phenethyl-4-piperidine (ANPP) ................................................................................................................................. 8333 II 

Norfentanyl .................................................................................................................................................................................. 8366 II 

Phenylacetone ............................................................................................................................................................................. 8501 II 

1-Piperidinocyclohexanecarbonitrile ............................................................................................................................................ 8603 II 

Alphaprodine ................................................................................................................................................................................ 9010 II 

Anileridine .................................................................................................................................................................................... 9020 II 

Cocaine ........................................................................................................................................................................................ 9041 II 

Codeine ....................................................................................................................................................................................... 9050 II 

Etorphine HCl .............................................................................................................................................................................. 9059 II 

Dihydrocodeine ............................................................................................................................................................................ 9120 II 

Oxycodone ................................................................................................................................................................................... 9143 II 

Hydromorphone ........................................................................................................................................................................... 9150 II 

Diphenoxylate .............................................................................................................................................................................. 9170 II 

Ecgonine ...................................................................................................................................................................................... 9180 II 

Ethylmorphine .............................................................................................................................................................................. 9190 II 

Hydrocodone ............................................................................................................................................................................... 9193 II 

Levomethorphan .......................................................................................................................................................................... 9210 II 

Levorphanol ................................................................................................................................................................................. 9220 II 

Isomethadone .............................................................................................................................................................................. 9226 II 

Meperidine ................................................................................................................................................................................... 9230 II 

Meperidine intermediate-A .......................................................................................................................................................... 9232 II 

Meperidine intermediate-B .......................................................................................................................................................... 9233 II 

Meperidine intermediate-C .......................................................................................................................................................... 9234 II 

Metazocine .................................................................................................................................................................................. 9240 II 

Oliceridine .................................................................................................................................................................................... 9245 II 

Methadone ................................................................................................................................................................................... 9250 II 

Methadone intermediate .............................................................................................................................................................. 9254 II 

Metopon ....................................................................................................................................................................................... 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) .......................................................................................................................... 9273 II 

Morphine ...................................................................................................................................................................................... 9300 II 

Oripavine ..................................................................................................................................................................................... 9330 II 


ddrumheller on DSK120RN23PROD with NOTICES1
76152 Federal Register / Vol. 89, No. 180 / Tuesday, September 17, 2024 / Notices 

Controlled substance Drug 

code Schedule 

Thebaine ...................................................................................................................................................................................... 9333 II 

Dihydroetorphine ......................................................................................................................................................................... 9334 II 

Levo-alphacetylmethadol ............................................................................................................................................................. 9648 II 

Oxymorphone .............................................................................................................................................................................. 9652 II 

Noroxymorphone ......................................................................................................................................................................... 9668 II 

Phenazocine ................................................................................................................................................................................ 9715 II 

Thiafentanil .................................................................................................................................................................................. 9729 II 

Piminodine ................................................................................................................................................................................... 9730 II 

Racemethorphan ......................................................................................................................................................................... 9732 II 

Racemorphan .............................................................................................................................................................................. 9733 II 

Alfentanil ...................................................................................................................................................................................... 9737 II 

Remifentanil ................................................................................................................................................................................. 9739 II 

Sufentanil ..................................................................................................................................................................................... 9740 II 

Carfentanil ................................................................................................................................................................................... 9743 II 

Tapentadol ................................................................................................................................................................................... 9780 II 

Bezitramide .................................................................................................................................................................................. 9800 II 

Fentanyl ....................................................................................................................................................................................... 9801 II 

Moramide-intermediate ................................................................................................................................................................ 9802 II 

The company plans to bulk 

manufacture the listed controlled 

substances for distribution to its 

customers. In reference to dug codes 

7360 (Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Marsha L. Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–21062 Filed 9–16–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1432] 

Bulk Manufacturer of Controlled 

Substances Application: Eli-Elsohly 

Laboratories 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Eli-Elsohly Laboratories has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before November 18, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before November 18, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on August 16, 2024, EliElsohly Laboratories, 5 Industrial Park 

Drive, Oxford, Mississippi 38655–5343, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract .......... 7350 I 

Marihuana ....................... 7360 I 

Tetrahydrocannabinols ... 7370 I 

Dihydromorphine ............ 9145 I 

Amphetamine ................. 1100 II 

Methamphetamine .......... 1105 II 

Cocaine .......................... 9041 II 

Codeine .......................... 9050 II 

Dihydrocodeine ............... 9120 II 

Oxycodone ..................... 9143 II 

Ecgonine ......................... 9180 II 

Thebaine ......................... 9333 II 

The company plans to manufacture 

the listed controlled substances for 

product development reference 

standards. In reference to drug codes 

7360 (Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to isolate these controlled 

substances from procured 7350 

(Marihuana Extract). In reference to 

drug code 7360, no cultivation activities 

are authorized for this registration. 

In reference to drug code 9333 

(Thebaine), the company plans to 

manufacture a Thebaine derivative. No 

other activities for these drug codes are 

authorized for this registration. 

Marsha L. Ikner, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2024–21060 Filed 9–16–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. 23–53] 

George D. Gowder, III, M.D.; Decision 

and Order 

On July 18, 2023, the Drug 

Enforcement Administration (DEA or 

Government) issued an Order to Show 

Cause (OSC) to George Gowder, III, 

M.D., of Blairsville, Georgia 

(Respondent). OSC, at 1, 3. The OSC 

proposed the denial of Respondent’s 

application for a DEA Certificate of 

Registration (registration), Control No. 

W22147308C, alleging that Respondent 

has been convicted of a felony relating 

to Federal controlled substance laws, 

and that he has been excluded from 

participation in Medicare, Medicaid, 

and all Federal health care programs. Id. 

at 1–2 (citing 21 U.S.C. 823(g)(1), 

824(a)(2), 824(a)(5)). 

A hearing was held before DEA 

Administrative Law Judge Teresa A. 

Wallbaum (ALJ), who, on December 1, 

2023, issued her Recommended Rulings, 

Findings of Fact, Conclusions of Law, 

and Decision (Recommended Decision 

or RD). The RD recommended that 


ddrumheller on DSK120RN23PROD with NOTICES1